194 related articles for article (PubMed ID: 29440643)
21. Discovery of stimulation-responsive immune enhancers with CRISPR activation.
Simeonov DR; Gowen BG; Boontanrart M; Roth TL; Gagnon JD; Mumbach MR; Satpathy AT; Lee Y; Bray NL; Chan AY; Lituiev DS; Nguyen ML; Gate RE; Subramaniam M; Li Z; Woo JM; Mitros T; Ray GJ; Curie GL; Naddaf N; Chu JS; Ma H; Boyer E; Van Gool F; Huang H; Liu R; Tobin VR; Schumann K; Daly MJ; Farh KK; Ansel KM; Ye CJ; Greenleaf WJ; Anderson MS; Bluestone JA; Chang HY; Corn JE; Marson A
Nature; 2017 Sep; 549(7670):111-115. PubMed ID: 28854172
[TBL] [Abstract][Full Text] [Related]
22. A20: a master regulator of arthritis.
Wu Y; He X; Huang N; Yu J; Shao B
Arthritis Res Ther; 2020 Sep; 22(1):220. PubMed ID: 32958016
[TBL] [Abstract][Full Text] [Related]
23. Contribution of transposable elements and distal enhancers to evolution of human-specific features of interphase chromatin architecture in embryonic stem cells.
Glinsky GV
Chromosome Res; 2018 Mar; 26(1-2):61-84. PubMed ID: 29335803
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
[TBL] [Abstract][Full Text] [Related]
25. Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma.
Kedra J; Seror R; Dieudé P; Constantin A; Toussirot E; Kfoury E; Masson C; Cornec D; Dubost JJ; Marguerie L; Ottaviani S; Grados F; Belkhir R; Fain O; Fautrel B; Philippe P; Piperno M; Combe B; Lambotte O; Richez C; Sellam J; Sené T; Denis G; Lequerre T; Lazure T; Mariette X; Nocturne G
Joint Bone Spine; 2022 Oct; 89(5):105390. PubMed ID: 35490943
[No Abstract] [Full Text] [Related]
26. A20: A multifunctional tool for regulating immunity and preventing disease.
Malynn BA; Ma A
Cell Immunol; 2019 Jun; 340():103914. PubMed ID: 31030956
[TBL] [Abstract][Full Text] [Related]
27. A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.
Fujii M; Takata K; Chuang SS; Miyata-Takata T; Ando M; Sato Y; Yoshino T
Acta Med Okayama; 2018 Feb; 72(1):23-30. PubMed ID: 29463935
[TBL] [Abstract][Full Text] [Related]
28. An Autoimmune Disease-Associated Risk Variant in the
Lou L; Bao W; Liu X; Song H; Wang Y; Zhang K; Gao W; Li H; Tu Z; Wang S
J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29343543
[TBL] [Abstract][Full Text] [Related]
29. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
30. A20/TNFAIP3 Regulates the DNA Damage Response and Mediates Tumor Cell Resistance to DNA-Damaging Therapy.
Yang C; Zang W; Tang Z; Ji Y; Xu R; Yang Y; Luo A; Hu B; Zhang Z; Liu Z; Zheng X
Cancer Res; 2018 Feb; 78(4):1069-1082. PubMed ID: 29233925
[TBL] [Abstract][Full Text] [Related]
31. Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants.
Aune TM; Crooke PS; Patrick AE; Tossberg JT; Olsen NJ; Spurlock CF
J Autoimmun; 2017 Jul; 81():99-109. PubMed ID: 28420548
[TBL] [Abstract][Full Text] [Related]
32. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis.
Zhu L; Wang L; Wang X; Zhou L; Liao Z; Xu L; Wu H; Ren J; Li Z; Yang L; Chen S; Li B; Wu X; Zhou Y; Li Y
J Transl Med; 2015 Jul; 13():215. PubMed ID: 26143186
[TBL] [Abstract][Full Text] [Related]
33. Di-(2-ethylhexyl) phthalate suppresses IL-12p40 production by GM-CSF-dependent macrophages via the PPARα/TNFAIP3/TRAF6 axis after lipopolysaccharide stimulation.
Yamaguchi R; Sakamoto A; Yamamoto T; Narahara S; Sugiuchi H; Hisada A; Katoh T; Yamaguchi Y
Hum Exp Toxicol; 2018 Jun; 37(6):596-607. PubMed ID: 28673093
[TBL] [Abstract][Full Text] [Related]
34. Denisovan, modern human and mouse TNFAIP3 alleles tune A20 phosphorylation and immunity.
Zammit NW; Siggs OM; Gray PE; Horikawa K; Langley DB; Walters SN; Daley SR; Loetsch C; Warren J; Yap JY; Cultrone D; Russell A; Malle EK; Villanueva JE; Cowley MJ; Gayevskiy V; Dinger ME; Brink R; Zahra D; Chaudhri G; Karupiah G; Whittle B; Roots C; Bertram E; Yamada M; Jeelall Y; Enders A; Clifton BE; Mabbitt PD; Jackson CJ; Watson SR; Jenne CN; Lanier LL; Wiltshire T; Spitzer MH; Nolan GP; Schmitz F; Aderem A; Porebski BT; Buckle AM; Abbott DW; Ziegler JB; Craig ME; Benitez-Aguirre P; Teo J; Tangye SG; King C; Wong M; Cox MP; Phung W; Tang J; Sandoval W; Wertz IE; Christ D; Goodnow CC; Grey ST
Nat Immunol; 2019 Oct; 20(10):1299-1310. PubMed ID: 31534238
[TBL] [Abstract][Full Text] [Related]
35. Haploinsufficiency of TNFAIP3 (A20) by germline mutation is involved in autoimmune lymphoproliferative syndrome.
Takagi M; Ogata S; Ueno H; Yoshida K; Yeh T; Hoshino A; Piao J; Yamashita M; Nanya M; Okano T; Kajiwara M; Kanegane H; Muramatsu H; Okuno Y; Shiraishi Y; Chiba K; Tanaka H; Bando Y; Kato M; Hayashi Y; Miyano S; Imai K; Ogawa S; Kojima S; Morio T
J Allergy Clin Immunol; 2017 Jun; 139(6):1914-1922. PubMed ID: 27845235
[TBL] [Abstract][Full Text] [Related]
36. Enhancer redundancy provides phenotypic robustness in mammalian development.
Osterwalder M; Barozzi I; Tissières V; Fukuda-Yuzawa Y; Mannion BJ; Afzal SY; Lee EA; Zhu Y; Plajzer-Frick I; Pickle CS; Kato M; Garvin TH; Pham QT; Harrington AN; Akiyama JA; Afzal V; Lopez-Rios J; Dickel DE; Visel A; Pennacchio LA
Nature; 2018 Feb; 554(7691):239-243. PubMed ID: 29420474
[TBL] [Abstract][Full Text] [Related]
37. Rare variants, autoimmune disease, and arthritis.
Chung SA; Shum AK
Curr Opin Rheumatol; 2016 Jul; 28(4):346-51. PubMed ID: 27224741
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
39. Expanding the spectrum of A20 haploinsufficiency in two Chinese families: cases report.
Li GM; Liu HM; Guan WZ; Xu H; Wu BB; Sun L
BMC Med Genet; 2019 Jul; 20(1):124. PubMed ID: 31299923
[TBL] [Abstract][Full Text] [Related]
40. A20 promotes metastasis of aggressive basal-like breast cancers through multi-monoubiquitylation of Snail1.
Lee JH; Jung SM; Yang KM; Bae E; Ahn SG; Park JS; Seo D; Kim M; Ha J; Lee J; Kim JH; Kim JH; Ooshima A; Park J; Shin D; Lee YS; Lee S; van Loo G; Jeong J; Kim SJ; Park SH
Nat Cell Biol; 2017 Oct; 19(10):1260-1273. PubMed ID: 28892081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
